Quantitative Systematic Strategies LLC Horizon Therapeutics Public LTD CO Transaction History

Quantitative Systematic Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$91.91 - $110.37 $972,132 - $1.17 Million	-10,577 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $1.29 Million - $1.43 Million	-14,926 Reduced 58.53%	10,577 $990,000
Q1 2021 May 06, 2021	SELL	$71.83 - $95.48 $1.11 Million - $1.47 Million	-15,437 Reduced 37.71%	25,503 $2.35 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $1.13 Million - $1.42 Million	16,829 Added 69.8%	40,940 $3 Million
Q3 2020 Nov 09, 2020	SELL	$55.23 - $79.93 $697,168 - $1.01 Million	-12,623 Reduced 34.36%	24,111 $1.87 Million
Q2 2020 Aug 04, 2020	BUY	$30.2 - $56.98 $411,928 - $777,207	13,640 Added 59.06%	36,734 $2.04 Million
Q1 2020 May 06, 2020	BUY	$24.87 - $38.56 $141,211 - $218,943	5,678 Added 32.6%	23,094 $684,000
Q4 2019 Feb 11, 2020	BUY	$25.43 - $36.67 $208,882 - $301,207	8,214 Added 89.26%	17,416 $630,000
Q3 2019 Nov 07, 2019	SELL	$23.0 - $27.97 $86,664 - $105,390	-3,768 Reduced 29.05%	9,202 $251,000
Q2 2019 Jul 25, 2019	BUY	$22.81 - $28.48 $295,845 - $369,385	12,970 New	12,970 $312,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.